Cargando...
The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations
Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the obstructive airway diseases and patients experience worse outcomes compared with asthma or COPD alone. Patients wit...
Gardado en:
| Publicado en: | Expert Rev Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7046086/ https://ncbi.nlm.nih.gov/pubmed/23473596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/ecp.13.2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|